The Oversight Committee holds a hearing to examine the high cost of biotech medicines to our health care system, as well the prospects and need for a pathway that would allow the FDA to approve safe and affordable generic versions of biotech drugs. Here Chairman Henry Waxman gives opening remarks.
91 total views, 2 so far today
by Editor on March 10, 2010 - 4 Comments
Read the full article:Newsweek recently indulged in yellow journalism, with Oprah on the cover with the headline: CrazyTalk, Oprah, Wacky Cures & You. The...
by Editor on February 14, 2010 - 2 Comments
Writing a thesis is definitely not biology childâ? S playing and writing to a relevant issue requires consultation with top high concentrations. Â picking the...
by Editor on February 1, 2010 - 2 Comments
This video can be downloaded here: www.ashdenawards.org BIOTECH won an Ashden Award for Sustainable Energy in 2007. To find out ...
by Editor on March 5, 2010 - 1 Comments
To obtain biotechnological medicines, cereals, vegetables and animals on the market for human consumption must be U.S. biotech companies to go their products th...
by Editor on March 29, 2010 - 1 Comments
Cha Kwang Yul M. D for Largest Stem Cell Research Although 'Hwang Woo-Suk stem cell fraud scandal rocked Korean wants to emerge as bioscience hub, Korea con...
© 2010 Biotech Career. All Rights Reserved.
